Certara

PriceCertara

CERT

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Historical stock price chart and annual return over the past years

-73%

4 years

% Total

CERT
-23%

4 years

Annual Return

CERT